טוען...
The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease
BACKGROUND: Better treatment during early stages of chronic kidney disease (CKD) may slow progression to end-stage renal disease and decrease associated complications and medical costs. Achieving early treatment of CKD is challenging, however, because a large fraction of persons with CKD are unaware...
שמור ב:
| הוצא לאור ב: | BMC Nephrol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5347833/ https://ncbi.nlm.nih.gov/pubmed/28288579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-017-0497-6 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|